The T24 cells displayed higher CDK6 protein expression levels and more sensitivity to CDK4/6 inhibitors than those of the 5637 cells, suggesting that sensitivity to CDK4/6 inhibitors is accompanied by CDK6 protein expression levels in BLCA. The gene discussed is CDK4; the disease is bladder transitional cell carcinoma.